{"adverse_reactions":["• ADVERSE EVENTS To facilitate Adverse Event Reporting: www.fda.gov/medwatch or 1-800-FDA-1088."],"dosage_and_administration":["• DOSAGE AND ADMINISTRATION. FOR SLOW INTRAVENOUS USE ONLY. PRESERVATIVE-FREE INJECTION SOLUTION. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit."],"dosage_forms_and_strengths":["• INGREDIENTS Each 1 mL contains 1 mg neostigmine methylsulfate in Water for Injection q.s. The aqueous solution is adjusted to a pH of 5.0- 6.5 with acetic acid and/or sodium hydroxide, if necessary."],"effective_time":"20171206","how_supplied":["• HOW SUPPLIED Neostigmine Methylsulfate is supplied as a sterile, nonpyrogenic solution that is clear, colorless in a 5 mL Single Use Syringe. This product is Preservative-Free and Latex-Free."],"id":"5fae791e-af67-3bdc-e053-2a91aa0ae801","openfda":{},"package_label_principal_display_panel":["image description"],"set_id":"86963fc9-468c-4842-a76a-c5c1f5510c75","spl_product_data_elements":["Neostigmine Methylsulfate Neostigmine Methylsulfate WATER NEOSTIGMINE METHYLSULFATE NEOSTIGMINE"],"spl_unclassified_section":["Rx Only Rev. 02/15 CANTRELL DRUG COMPANY LITTLE ROCK, AR 72207"],"storage_and_handling":["• STORAGE AND HANDLING Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Protect from light."],"version":"2","warnings_and_cautions":["• WARNINGS AND PRECAUTIONS Outsourced Compounded Drug. Not for Resale. Hospital/Office Use Only."]}